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The mammalian pancreas is known to show a remarkable degree of regenerative ability. Several studies until now have demonstrated that the
mammalian pancreas can regenerate in normal as well as diabetic conditions. These studies illustrate that pancreatic transcription factors that are
seen to be expressed in a temporal fashion during development are re-expressed during regeneration. The only known exception to this is
Neurogenin3 (NGN3). Though NGN3 protein, which marks all the pro-endocrine cells during development, is not seen during mouse pancreas
regeneration, functional neo-islets are generated by 4 weeks after 70% pancreatectomy. We observed that pancreatic transcription factors upstream
of ngn3 showed similar gene expression patterns during development and regeneration. However, gene transcripts of transcription factors
immediately downstream of ngn3 (neuroD and nkx2.2) did not show such similarities in expression. Since NGN3 protein was not detected at any
time point during regeneration, we reasoned that post-transcriptional silencing of ngn3 by microRNAs may be a possible mechanism. We carried
out microRNA analysis of 283 known and validated mouse microRNAs during different stages of pancreatic development and regeneration and
identified that 4 microRNAs; miR-15a, miR-15b, miR-16 and miR-195, which can potentially bind to ngn3 transcript, are expressed at least 200-
fold higher in the regenerating mouse pancreas as compared to embryonic day (e) 10.5 or e 16.5 developing mouse pancreas. Inhibition of these
miRNAs in regenerating pancreatic cells using anti-sense miRNA-specific inhibitors, induces expression of NGN3 and its downstream players:
neuroD and nkx2.2. Similarly, overexpression of miRNAs targeting ngn3 during pancreas development shows reduction in the number of
hormone-producing cells. It appears that during pancreatic regeneration in mice, increased expression of these microRNAs allows endocrine
regeneration via an alternate pathway that does not involve NGN3 protein. Our studies on microRNA profiling of developing and regenerating
pancreas provide us with better understanding of mechanisms that regulate post-natal islet neogenesis.
© 2007 Elsevier Inc. All rights reserved.Keywords: Pancreas development; Regeneration; Pancreatectomy; microRNA; Neurogenin3Introduction
Failure in maintenance of pancreatic β-cell mass is
recognized to be a major player in pathogenesis of type 1 and
type 2 diabetes mellitus. Insulin replacement therapy, achieved
by transplantation of cadaveric pancreatic insulin-producing
cells, has been demonstrated with some success (Harlan and
Rother, 2004; Shapiro et al., 2000). However, an alternative⁎ Corresponding author. Fax: +91 20 2569 2259.
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doi:10.1016/j.ydbio.2007.09.008approach to islet transplantation is stimulation of endogenous
pancreatic β-cell regeneration. Regeneration of endocrine as
well as exocrine pancreas has been shown to occur in mice
under non-diabetic as well as diabetic conditions (Bonner-Weir
et al., 1993; Hardikar et al., 1999). Understanding the
mechanisms involved in β-cell development and regeneration
will enlighten therapeutic efforts to augment the number of
functional β-cells in patients with diabetes.
Endocrine pancreas development in mice begins at the
junction of foregut and midgut as dorsal and ventral budding of
the gut tube (Schwitzgebel et al., 2000; Wells, 2003). As the gut
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with each other to form the definitive pancreas and endocrine
cells are generated from duct-like structures in the developing
pancreas. At embryonic day (e) 14, the termini of these duct-like
structures form acini and differentiate into exocrine cells. At this
time (“secondary transition”), there is a huge increase in the
transcript level as well as number of insulin producing cells
(Sander et al., 2000; Wang et al., 2005). During mouse pancreas
development, cell fate is determined by a very nicely regulated
and synchronized spatio-temporal expression of transcription
factors, of which Neurogenin3 (NGN3), a bHLH transcription
factor, marks pancreatic endocrine progenitor cells, as con-
firmed by lineage tracing studies (Gu et al., 2002). NGN3
protein is detected largely during the 2nd trimester and is not
seen in mature islet cells. Ngn3−/− mice show no islet
development (Gradwohl et al., 2000) and transgenic over-
expression of ngn3 results in the activation of an islet
differentiation program in vivo as well as in cultured pancreatic
duct cell lines (Herrera et al., 2002; Huang et al., 2000; Noguchi
et al., 2006). The number of NGN3+ cells increases and peaks at
e 15.5, after which, expression gradually declines but is still
detectable in the neonatal period (Gasa et al., 2004; Heremans et
al., 2002; Schwitzgebel et al., 2000). Ngn3 expression or
immunopositivity is not seen in insulin- and glucagon-
producing cells, suggesting that ngn3 expression is not
necessary for post-natal islet function (Gasa et al., 2004;
Heremans et al., 2002; Schwitzgebel et al., 2000).
Although expression of neurogenin3 in the adult mouse
pancreas has not been reported as yet, it has been suggested that
islet regeneration in adult organisms recapitulates embryonic
developmental pathways (Bonner-Weir et al., 1993).
Recently, it was reported that NGN3 immunopositivity is not
detected during pancreas regeneration (Lee et al., 2006). This
study also demonstrates that even after administration of the β-
cell trophic glucagon-like peptide-1 receptor agonist exendin-4,
NGN3 immunopositivity was not seen (Lee et al., 2006). These
investigators, however, did not look at ngn3 transcripts during
regeneration (personal communications with Doris A. Stoffers).
We observed that ngn3 transcript is detectable during develop-
ment, post-natal life as well as during pancreatic regeneration
following partial pancreatectomy. However, no immunopositive
cells were visualized during regeneration, consistent with
previous report using ngn3-EGFP mice (Lee et al., 2006). We
reasoned that ngn3 transcripts may be post-transcriptionally
regulated and looked at expression of small RNA molecules
(microRNAs) that have recently been identified as important
regulators of post-transcriptional gene expression (Carthew,
2006; Engels and Hutvagner, 2006). MicroRNAs (miRNAs) are
approximately 22-nucleotides long, evolutionary conserved
class of non-protein-coding RNA molecules. These are known
to act by negatively regulating gene expression at the post-
transcriptional level (Alvarez-Garcia and Miska, 2005; Lagos-
Quintana et al., 2002; Lau and Lai, 2005) either by blocking
translation through incomplete binding to the 3′UTR of their
target mRNA, as in C. elegans, or, by directing degradation of
the target mRNA, as in Arabidopsis thaliana. It is believed that
this decision between translational repression or target mRNAdegradation is taken based on the level of complementarity
between miRNA seed-sequence (first 2 to 8 bases of miRNA)
and binding site on target mRNA. Presently, several hundreds of
such miRNAs have been identified in the mouse genome and
fewer of these have been validated (Berezikov et al., 2006).
Studies carried out in the last few years indicate importance of
miRNAs in regulation of insulin secretion (Poy et al., 2004),
adipocyte differentiation (Esau et al., 2004) and neural stem cell
fate (Smirnova et al., 2005). We now are beginning to
understand that miRNAs play an important role in gene
regulation and protein expression, a process that is delicately
orchestrated during embryonic development. We carried out
miRNA profiling of developing and regenerating pancreas to
gain insights into mechanisms that regulate islet β-cell
regeneration. High expression of miRNAs targeting ngn3
(miR-15a, miR-15b, miR-16 and miR-195) during pancreas
regeneration indicates a possible mechanism of post-transcrip-
tional regulation of ngn3.Materials and methods
Mice breeding and isolation of developing pancreas
Six- to 8-week-old FVB/NJ mice were obtained from Jackson Laboratories
(Bar Harbor, ME) and maintained at the experimental animal facility of National
Center for Cell Science according to guidelines outlined by the Institute's animal
care and use committee. Breeding pairs were set and pregnancy was confirmed
by observing vaginal smears. Pregnant females and newborn mice were
euthanized at pre-defined intervals and pancreatic buds or pancreas was
carefully dissected out using a stereo microscope. Pancreatic tissue samples at
each of these time points were taken for RNA isolation and immunostaining. For
RNA isolations, pancreatic samples were collected in Trizol (Invitrogen,
Carlsbad, CA). Isolated islets or tissues for immunostaining were fixed in 4%
freshly prepared paraformaldehyde and taken for immunocytochemistry.
Pancreatectomy and isolation of regenerating pancreas
Pancreatectomy (Px) was performed on 6- to 8-week-old male FVB/NJ mice
following the procedures described elsewhere (Hardikar et al., 1999). Briefly,
ketamine (150 mg/kg) and xylazine (10 mg/kg) were given intraperitoneally to
anesthetize the mice. The abdomen was opened through a left lateral incision (as
shown in Fig. S1) and around 70% of the total pancreatic tissue (as confirmed in
a pilot study) was carefully removed. Incisions were closed using 4-0 absorbable
sutures (Davis-Geck, Manati, PR) and autoclip wound clipper (BD, Franklin
Lakes, NJ). Topical ointment (Soframycin®, Aventis Pharma. Ltd., Pune, India)
was applied over the sutured wounds following surgery and animals were
administered analgesics (Buprenorphine 0.05 mg/kg every 12 h for 3 days). To
estimate the number of proliferative nuclei, 3 mice at each time point were
injected with 200 mg/kg of BrdU, 6 h prior to euthanasia. Animals were
sacrificed at predefined time points and regenerating pancreas were removed for
RNA isolation or fixed in freshly prepared 4% paraformaldehyde. BrdU
incorporation was detected every day using a monoclonal antibody (Sigma, St.
Louis, MO) during first 10 post-operative days.
RNA isolation and quantitative real-time PCR
Tissue samples were homogenized and frozen in Trizol (Invitrogen,
Carlsbad, CA). RNA was isolated as per the manufacturers' instructions,
measured on ND-1000 spectrophotometer (NanoDrop Technologies, Wilming-
ton, DE) and taken for reverse transcription/quantitative real-time PCR. First
strand cDNA synthesis was carried out using ‘high capacity cDNA archive kit’
(Applied Biosystems, Foster City, CA). PCR was performed in 5 μl or 10 μl total
volume in 96-well plates using cDNA prepared from 100 ng of total RNA on a
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Primers and probes were Assay-on-Demand (Applied Biosystems, Foster City,
CA). For estimation of fold-changes by qRT-PCR when the initial transcript
levels were undetectable, the initial Ct value was assigned to be 38, which would
lead to a possible underestimation of the actual fold-change. All qRT-PCR
results were normalized to 18S (VIC-labeled) ribosomal RNA carried out in
duplex reaction (with FAM labeled target gene probes) to correct for any
differences in RNA input. Conventional PCR was carried out on reverseFig. 1. Pancreas development and regeneration. (A) Pancreatic islet hormones (pro-i
during development and regeneration. Data are mean±S.E.M. for 3 mice each and rep
real-time PCR. Eight-week-old adult mice show no significant BrdU incorporation
Regenerating pancreatic islets (arrows) show increased BrdU incorporation by day
(N50 μm internal diameter) and islets at different days following pancreatectomy are
each. Scale bar represents 50 μm.transcribed samples using AmpliTaq Gold (Applied Biosystems, Foster City,
CA) and known/published primers (primer sequences for β-actin and NeuroD
are available from the authors upon request). All PCR reactions were analyzed
after 35 cycles of amplification.
For microRNA detection, complete mouse miRNA panel (Applied
Biosystems, Foster city, CA) including 283 miRNAs was used. Reverse
transcription was carried out using mature miRNA-specific primer sets (Applied
Biosystems, Foster City, CA) and microRNA reverse transcription kit (Appliednsulin2 and pro-glucagon) and regeneration genes (reg3a and reg3g) expression
resent fold increase over detectable (Ct value of 38), as assessed by quantitative
at day 0 (B) but increased proliferation in ducts (arrowheads) by day 3 (C).
10 (D). (E) BrdU+ cells in small ducts (b50 μm internal diameter), large ducts
quantified and presented as mean±S.E.M. from at least 2 mice and 10 sections
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Biosystems 7500 FAST system using miRNA-specific taqman-based probe-
primer sets (Applied Biosystems, Foster City, CA). All sample plates included
positive, negative and endogenous controls supplied by the manufacturer in
duplicate.
Immunostaining and confocal microscopy
Guinea pig anti-insulin antibody (Linco Research Inc, MO) and mouse anti-
glucagon (Sigma, St. Louis, MO) antibodies were used at 1:100 dilutions.
Rabbit anti-NeuroD (Chemicon Int. Inc, Temecula, CA) and mouse anti-
Neurogenin3 antibody (BD Biosciences, San Diego, CA) were used at 1:100
dilution. Alexa-Fluor 488, Alexa-Fluor 546 and Alexa-Fluor 633 F(ab′)2
secondary antibodies (Molecular Probes, OR) were used at 1:200 dilution.
Hoechst 33342 was used to visualize nuclei. Cells were fixed in 4% fresh
paraformaldehyde, permeabilized with chilled 50% methanol, blocked with 4%
normal donkey serum and then incubated with antisera. Primary antibodies were
incubated overnight at 4 °C, washed with PBS and then incubated with the
secondary antibodies at 37 °C for 1 h. Slides were washed extensively in PBS
and mounted in Mowiol. Confocal images were captured using a Zeiss LSM 510Fig. 2. Pancreatic transcription factors expressed during development and regeneratio
or day 26 post-pancreatectomy (B). Scale bar represents 50 μm. (C) Brief overview
during development. Transcript abundance of pancreatic transcription factors as esti
mean±S.E.M. over detectable (Ct of 38).laser scanning microscope using a 63×/1.3 oil objective with optical slices
∼0.8 μm. Magnification, laser and detector gains were set below saturation and
were identical across samples. Results presented are representative fields
confirmed from at least 5 different experiments.
Cell culture and anti-sense studies
Since levels of miRNAs specific for ngn3 increased by day 3 after
regeneration, we took out regenerating pancreas 24 h after pancreatectomy. The
regenerating pancreatic tissue obtained was finely chopped and digested with
collagenase to prepare single cell suspension. These were transfected with
antisense miRNAs (Ambion, Austin, TX) specifically designed and validated
against miR-15a, miR-15b, miR-16 and miR-195 or mutants in which the ‘seed
sequence’ (first 8 bases) was altered. The seed sequence for miR-15a, -15b, -16
and -195 is UAGCAGCAC while the seed sequence designed for mutant miR
was ACUGCAGUG. siPORT NeoFX, a lipid based reagent (Ambion, Austin,
TX), was used for transfection as per the manufacturer's recommendations.
Briefy, siPORT NeoFX was diluted in Opti-MEM 1 medium and incubated at
room temperature for 10 min. MicroRNA inhibitors or mutant-anti-miRNAwere
diluted in Opti-MEM to a final concentration of 30 nM. Diluted RNA andn. Confocal optical section of pancreatic islets isolated from day 1 neonates (A)
of temporal sequence of pancreatic transcription factors known to be expressed
mated by duplex quantitative real-time PCR is plotted (D–I) as fold increase of
Fig. 3. NeuroD expression during development and regeneration. (A) NeuroD
transcript is detectable during development but not at any point during
regeneration. Relative quantization presented here is a representative of 3
different biological replicates. (B) During development a few NeuroD (red
arrowheads), immunopositive cells show co-expression of islet hormones
(insulin in green and glucagon in pink). However, we could not detect NeuroD
immunopositive cells during regeneration though islet hormone-positive cells
appeared (mostly closer to ducts) in the regenerating pancreas. Scale bar
represents 20 μm.
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temperature for 10 min. The RNA/siPORT NeoFX complexes were then
distributed to each well and overlaid with cell suspension. Cells harvested after 4
or 6 days of transfection were taken for transcript analysis (neuroD and nkx2.2)
and immunostaining.
Target prediction and cluster analysis
Since mammalian miRNAs are generally thought to recognize 3′UTR of
target mRNA via partial complementarity, we used carefully designed
computational approaches to predict mRNA targets for mammalian miRNAs.
Two target search engines fromMemorial Sloan-Kettering Cancer Center (http://
www.microrna.org/), miRanda software and target analysis by PicTar (http://
pictar.bio.nyu.edu/) were mainly used to confirm targets for specific miRNAs.
Normalized data sets from real-time PCR analysis of miRNA expression profiles
were taken as input data for bi-directional clustering. Bi-directional clustering is
one of the most widely used algorithms to recognize patterns in data sets with
similar expression profiles. Since functional modules of genes are generally
regulated together, such modules can be identified from the similarity of their
expression patterns in a bi-directional analysis. Two-way clustering was
performed in MatLab™, using the Bioinformatics Tool-box (MatLab™ v 7.0,
R 14), which basically groups the samples with similar matching gene profiles
together across the X-axis. Genes within these grouped samples that show
similar expression patterns are grouped together along the Y-axis. Bi-directional
clustering thus offers an important tool to assess closely related samples as well
as similar gene expression pattern within these sample groups.
Results and discussion
Islet hormones show similar gene expression patterns during
development and regeneration
Pancreatic regeneration after pancreatectomy has been well
characterized (Bonner-Weir et al., 1993; Bonner-Weir and Weir,
2005; Hardikar, 2004; Hardikar et al., 1999) using several
transgenic and knockout mice. We assessed islet (pro-)
hormones and transcription factors expressed during mouse
pancreatic development by multiplex quantitative real-time
PCR (qRT-PCR). We found that mouse pro-insulin2 and pro-
glucagon gene transcripts are expressed at detectable levels as
early as e 10.5 (Fig. 1A). By e 16.5, we detect a massive
(N1000-fold) increase in the levels of gene transcripts for these
2 islet hormones (Fig. 1A). This is rather expected as most of the
islet development/differentiation occurs during the second
trimester (Sanders and Rutter, 1974; Watada, 2004). There is
no significant change later on in abundance of pro-insulin2 and
pro-glucagon transcripts during post-natal period or by 8 weeks
(Fig. 1A). We then carried out pancreatectomy on 8-week-old
mice (Fig. S1) and removed ∼70% of total pancreatic mass.
This resulted in around 10- to 100-fold decrease in levels of
pancreatic islet hormone gene transcripts (Fig. 1A) by 3 days
post-Px. Pro-insulin2 gene transcripts increased and stabilized
to pre-operative levels by end of 4 weeks. Pancreatic islet
regeneration-associated gene transcripts (reg3a and reg3g)
showed 100-fold more abundance (Fig. 1A) at 3 days post-
Px. By 4 weeks after pancreatectomy, levels of reg3a and reg3g
stabilized down to pre-operative levels. Since pancreatic
regeneration is known to involve islet-, duct- or acinar-cell
proliferation, we looked at BrdU-incorporation in these cells
during pancreas regeneration. Following partial pancreatect-
omy, we observed increase in pancreatic duct as well as islet cell
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in small and large ducts and then later on in islets (Fig. 1E).
Recent promoter-based lineage tracing studies have demon-
strated that reconstitution of pancreatic mass following surgical
resection occurs primarily via proliferation of endocrine,
exocrine and ductal tissue (Brennand et al., 2007; Desai et al.,
2007; Strobel et al., 2007), which give rise to respective cells in
the regenerated pancreas. We observed BrdU immunopositivity
in each of these pancreatic ‘compartments’ and believe that
proliferation of exocrine, endocrine as well as ductal-cells plays
an important role in reconstitution of the entire organ.
Pancreatic transcription factors upstream of ngn3 show
similar expression during development and regeneration
We looked at expression of pancreatic islet hormones in day
1 neonates (Fig. 2A) as well as 26-days post-Px in adult mice
(Fig. 2B). There are no differences in the % of insulin- and
glucagon-immunopositive cells between islets isolated from
day 1 neonates (67±2%) or day 26 regenerated pancreas (76±
3%; pN0.05). These data demonstrate that de novo development
of hormone-producing cells or pancreatic regeneration follow-
ing pancreatectomy leads to generation of islets that contain a
similar number of hormone-producing cells. To further under-
stand similarities in endocrine pancreas development and
regeneration, we assessed the transcript levels of several
transcription factors expressed during pancreas development
(illustrated in Fig. 2C). We found that pancreatic transcription
factors, such as hnf3β, pdx1 as well as ngn3 (which marks
endocrine progenitor cells), show similar increase in transcript
abundance during regeneration (Figs. 2D–F). Hnf3β, pdx1 and
ngn3 gene transcripts that are expressed at relatively lower
abundance by e 10.5 are seen to increase by e 16.5. The level of
gene transcripts for these transcription factors in 8-week-old
adult pancreas is similar to that seen in e 10.5 pancreatic buds.
In adult mice, gene transcripts for pdx1 and ngn3 show a similar
transient increase immediately after pancreatectomy (Figs. 2E,
F). Surprisingly, when we looked at pancreatic transcription
factors downstream of ngn3, we did not see a similar trend for
neuroD (Fig. 3A) or nkx2.2 (Fig. 2G). NeuroD immunoposi-
tivity was detectable during development at e 15.5–e 17.5, but
not during regeneration (Fig. 3B).
Differences in protein expression are actually due to
post-transcriptional regulation of ngn3 gene transcripts
Neurogenin3 is a bHLH transcription factor that has been
demonstrated to be essential for normal development of islet
cells. Previous studies have demonstrated that NGN3 immu-Fig. 4. Neurogenin3 expression during regeneration may be regulated by microRNA
but not at day 3 (or other time points not shown) following pancreatectomy in mous
different transcription factors (as outlined in Fig. 2C). Legend indicates the normalize
Ct value), to white color, representing low expression (high Ct value) of the miRN
threshold of 40 is considered undetectable. (C) Four different miRNAs that can po
embryos, but are rapidly over expressed at 3 days after pancreatectomy. (D) NeuroD t
vitro without or with transfection of mutant anti-miRNA. However, after co-transfec
neuroD. Data represents analysis from 4 biological replicates. Scale bar is 10 μm.nopositive cells, which are evident during pancreas develop-
ment, are not seen during pancreas regeneration (Lee et al.,
2006). In this study as well, we detect NGN3 immunopositive
cells during development but not at any point during pancreas
regeneration (Fig. 4A). Since the half-life of NGN3 protein
may be very short, Lee et al. also looked at ngn3 expression
after regeneration using ngn3-EGFP transgenic mice (Lee et
al., 2006). They could not detect any GFP-positive cells
following pancreatectomy and therefore concluded that neuro-
genin3 is not activated during pancreas regeneration. Interest-
ingly, when we looked at the construct used to derive the ngn3-
EGFP mice (Lee et al., 2002), we noticed that these mice were
generated by inserting the EGFP tag in coding region of ngn3
gene, while maintaining the 5′- as well as 3′-UTR intact. Since
we detected ngn3 transcript at very high abundance (Cycle
threshold (Ct) value 19–21) during regeneration, we thought
that ngn3 must be post-transcriptionally regulated via micro-
RNAs that could bind to 3′UTR of endogenous ngn3 (or ngn3-
EGFP) mRNA. We therefore decided to look at the expression
of 283 known/validated miRNAs during development and
regeneration. Two-dimensional cluster analysis of miRNAs
targeting transcription factors (outlined in Fig. 2C) indicated
that miRNA profiles of regenerated pancreas (day 26 and day
16 post-Px) were similar to adult 8-week-old mice. Such a
clustering pattern indicates that miRNA gene expression
patterns between day 26 (and 16) post-px and adult mice
have similar expression profiles. Likewise, day 9 post-Px
miRNA profiles were very similar to that of e 16.5 developing
pancreas, but not similar to those of the 3 day post-Px mice or
adult mice pancreas (Fig. 4B). These data demonstrate that
similarities in development and regeneration exist even at the
‘microRNA level’.
We then looked at miRNAs that could specifically bind to
ngn3. We came up with 7 microRNAs that could potentially
bind to 3′UTR of ngn3. Of these, 4 miRNAs, miR-15a, miR-
15b, miR-16 and miR-195 did not show any significant
change during development or on day 1 (Fig. 4C). However,
after partial pancreatectomy, these 4 miRNAs were seen to be
expressed at least 200-fold more at day 3 post-Px as
compared to those observed during development (Fig. 4C).
All of these miRNAs that bind to ngn3 carry a specific seed
sequence: UAGCAGCA, which refers first 2 to 8 bases of
these microRNAs. We also looked at miRNAs that showed no
similarity with this seed sequence. Four such miRNAs, some
of which target other pancreatic transcription factors but show
no similarity to ngn3-specific miRNAs, were not upregulated
at this time (Fig. S2B). Anti-miRs, which are anti-sense
miRNAs to 22 nt sequences of miR-15a, -15b, -16 and -195
were obtained from Ambion. We also generated mutant anti-s. (A) Neurogenin3 protein is detectable in developing pancreatic buds at e 12.5,
e. (B) Heatmap for microRNA profiling of miRNAs that can potentially bind to
d Cycle threshold (Ct) value from black color, representing high expression (low
A assessed. Intermediate expression is plotted in scales of red/orange. Cycle
tentially bind to neurogenin3 are expressed at levels similar to adult in e 10.5
ranscript is not detected in freshly isolated (day 1 post-Px) cells or after 4 days in
tion with inhibitors for miRNAs that target ngn3, these cells show expression of
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carry b25% similarities in remaining 12–14 bases after the
seed sequence. We transfected miRNA-specific anti-sense
RNAs into cells isolated from regenerating pancreas (day 1
post-Px) and looked at expression of downstream transcription
factors such as nkx2.2 and neuroD. We could detect expression
of neuroD (Fig. 4D) as well as nkx2.2 (not shown) following
transfection of anti-sense miRNAs into day 1 regenerating
pancreatic cells. Untransfected cells maintained under similar
culture conditions (Fig. 4D) or mutant anti-miRs transfected
into day 1 regenerating pancreatic cells did not show
expression of neuroD. NGN3 immunopositivity was detected
in 9.2±1.3% of regenerating pancreatic cells that were
transfected with specific miRNA inhibitors only but not in
cells that were transfected with mutant anti-miRNA or
untransfected cells. Nonetheless, it appears that expression of
NGN3 in these cells resulted in appearance of downstream
transcription factors such as neuroD (Fig. 4D).
Our data indicate that transient increases in miRNAs that
bind to ngn3 may be involved in inhibiting ngn3 translation
during regeneration. Absence of NGN3 protein during
regeneration also results in diminished expression of its
downstream gene targets. Most significant differences were
seen in the expression of neuroD and nkx2.2. Nkx2.2 was not
detectable at 3-, 9- or 16-days post-Px (Fig. 2G). We also
could not detect expression of neuroD (Fig. 3A) during
regeneration. However, other mature islet transcription factors
such as isl1, nkx6.1and pax6 are detected at lower levels (Ct
values up to mid-30s) during regeneration. These studies
indicate that though NGN3 protein is not produced during
regeneration (Fig. 4A), there are no differences in expression
of mature islet hormones (Figs. 1A and 2A, B) or transcription
factors (Fig. 2). We demonstrate that inhibition of ngn3-
translation affects transcription of downstream genes such as
neuroD (Fig. 3A) and nkx2.2 (Fig. 2G). However, when cells
isolated from regenerating pancreas were transfected with anti-
miRNAs to miR-15a, miR-15b, miR-16 and miR-195, we see
expression of NGN3 and transcription of downstream genes
such as neuroD (Fig. 4D). Mutant inhibitors did not result in
expression of neuroD (Fig. 4D). Since these miRNAs inhibit
ngn3 translation, we decided to look at the role of these
miRNAs during pancreas development. We overexpressed
ngn3-specific miRNA duplexes in e12.5 pancreatic buds and
looked at expression of islet endocrine cells at 4 days in vitro.
We observed that overexpression of miRNAs in developing
pancreatic buds led to reduction in the number of insulin and
glucagon-producing cells in developing pancreas (Fig. S3).
Developing pancreatic buds overexpressing these miRNAs
showed significantly lower number of insulin and glucagon-
producing cells (5.2±1%) as compared to control pancreatic
buds (15.1±1.8%, pb0.001). Our data demonstrate that
differences in gene expression during development and
regeneration exist at the level of post-transcriptional regulation
of neurogenin3, a gene that marks pro-endocrine cells during
pancreas development.
What may be the reasons for such differences during
development and regeneration? One plausible explanationmay be that pancreatic regeneration in mice following
pancreatectomy does not occur from the pancreatic “stem
cell” as is known to happen during embryonic development.
Some of the recent evidences indicate that replication of
existing β-cells may be one such mechanism for β-cell renewal
following pancreatectomy in adult mice (Dor et al., 2004). It is
possible that a more “committed” population of pancreatic islet
progenitor cells may be involved in generation of new hormone-
producing cells by an alternate route that does not involve
sequential activation of transcription factors. During embryonic
development, lineage tracing as well as knockout studies
presented by several groups has demonstrated that differentia-
tion of a pancreas-specific “stem cell” into hormone-producing
cell clusters involves temporal expression of several pancreatic
transcription factors. We believe that though such a temporal
expression of transcription factors is essential for normal
embryonic development, it may not be necessary during adult
life. The pancreas seems to suppress islet neogenesis via stem
cell pathway in the regenerating pancreas, following pancrea-
tectomy. Expression of these 4 miRNAs in other tissues (heart,
lungs, kidney and brain) does not change during this time (Fig.
S2C). The pancreas-specific increases in miRNAs targeting
ngn3 seem to prevent islet neogenesis via stem cells.
We think that there exists at least one (if not many) alternative
pathway(s) that contributes to islet neogenesis following
pancreatectomy in mice. Two recent reports using genetic
lineage tracing in mice provide evidence that following partial
pancreatectomy, pre-existing acinar cells contribute to genera-
tion of new acinar (but not islet) cell types (Desai et al., 2007)
and pre-existing islet β-cells contribute to generation of islet β-
cells, as demonstrated earlier (Dor et al., 2004), but not acinar
cells (Strobel et al., 2007). Thus islet neogenesis following
pancreatectomy does not seem to occur via the major (acinar)
pancreatic component. One begins to wonder about other
pathways that may be involved in generation of new islets,
following pancreatectomy in mice. Recent studies using serial
thymidine analog labeling (Teta et al., 2007) or promoter-based
gene expression studies (Brennand et al., 2007) provide
evidence that all pre-existing insulin-expressing (β-) cells
have a similar potential to contribute to “new islets” during
pancreas regeneration. Though these lineage tracing studies do
not support (nor fully refute) the possible contribution of
pancreatic duct cells, what seems evident is that the pancreatic
islet β-cells themselves may be one of the major contributors to
islet neogenesis following pancreatectomy. It appears to us that
in presence of such a “committed” progenitor cell (the β-cell
itself), islet neogenesis from stem cells would be a less
“favored” alternative. We demonstrate that active proliferation
of duct-, islet- as well as exocrine-cells occurs following
pancreatectomy in these mice (Figs. 1B–E). Our data are in
agreement with recent reports demonstrating proliferation of
these pancreatic compartments (ductal, endocrine and exocrine)
in restoration of the pancreas (Brennand et al., 2007; Strobel et
al., 2007; Teta et al., 2007) and we do believe that in the
presence of this alternate pathway (β-cell to β-cells), an islet
“stem-cell” dependent pathway is inhibited by a tissue-specific
increase in miRNAs targeting ngn3. We demonstrate here that
611M.V. Joglekar et al. / Developmental Biology 311 (2007) 603–612microRNA mediated regulation of neurogenin3 expression
allows regeneration of endocrine pancreas via an alternate
pathway that may not involve neogenesis from pancreatic “stem
cells”.
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